Search
Enlarge Text | Printable Version | Sitemap | Contact us
Research
Upcoming Events
Researcher Name: Chataway, J., Gehl Sampath, P., Kale, D., Tait, J. and Wield, D. Project Start Date: Project End Date: Contact Details: Joanna Chataway, Padmashree Gehl Sampath, Dinar Kale, Joyce Tait, David Wield Funder: Background: The pharmaceutical sector is heavily regulated and this influences industry structure and patterns of innovation. Product safety and efficacy regulation and patent regulation are particularly important in this respect. Innogen has carried out a wide range of work in relation to this theme and is concerned with both analyzing and understanding the impact of regulations, the way in which regulation interacts with other influences and the potential for revitalising innovation and shaping particular trajectories through regulatory evolution. Current reseach projects include: Revitalising Innovation though regulatory evolution (Various ongoing activities by Joyce Tait, Joanna Chataway and David Wield) Reorganisation of innovation in the health care life sciences (An Innogen core project led by James Mittra) Internationalisation of Indian pharma (An Innogen core project led by Dinar Kale with Raphie Kaplinsky) Indian Pharmaceutical Sector in 2008: Local and Global Implications for Access to Medicines (Various ongoing activities led by Padmashree Gehl Sampath) The drivers of biotechnology firm innovative performance in the health care sector (An Innogen core project led by Alessandro Rosiello with Paul Quintas) Legal and regulatory mechanisms (An Innogen core project led by Shawn Harmon and Graeme Laurie) Innovation in Pharma and equity in health (A broadly funded project led by Mariana Mazzucato with Maureen Mackintosh, Luigi Orsenigo, Rebecca Hanlin, Roberto Simonetti) Aims and Objectives: Research Methods: Key Findings: Wider implications for policy: Project Update: Publications: Kale, D. and Wield, D. (2008) . Industry and Innovation, 15 (1). pp. 93-114. ISSN 1366-2716 Archambault, E., Simonetti, R., Côté, G. and Kale, D. (2007) The dynamics of pharmaceutical patenting in India: Evidence from USPTO data. Technology Analysis and Strategic Management, 19 (5). pp. 625-642. ISSN 0953-7325 Chataway, J., Kale, D. and Wield, D. (2007) The Indian pharmaceutical industry before and after TRIPS. Technology Analysis and Strategic Management, 19 (5). pp. 559-563. ISSN 0953-7325 Chataway, J., Tait, J. and Wield, D. (2007) Frameworks for pharmaceutical innovation in developing countries: the case of Indian pharma. Technology Analysis and Strategic Management, 19 (5). pp. 697-708. ISSN 0953-7325 Gehl Sampath, P. (2007) Breaking the fence: can patents deter biomedical innovation in 'Technology Followers'?. Journal of Technology Assessment and Strategic Management, 19 (5). pp. 1-20. ISSN 1465-3990 Kale, D. and Little, S. (2007) From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry. Technology Analysis and Strategic Management, 19 (5). pp. 589-609. ISSN 1465-3990 Chataway, J., Tait, J. and Wield, D. (2006) The governance of agro- and pharmaceutical biotechnology innovation: public policy and industrial strategy. Technology Analysis and Strategic Management, 18 (2). pp. 169-185. ISSN 1465-3990 Tait, J., Chataway, J., Lyall, C. and Wield, D. (2006) Governance, policy and industry strategies: pharmaceuticals and agro-biotechnology. In: Knowledge accumulation and industry evolution: the case of Pharma-Biotech. Cambridge University Press, Cambridge, UK, pp. 378-401. ISBN 0-521-85822-4, 978-0-521-85822-9 Chaturvedi, K. and Chataway, J. (2006) Strategic Integration of knowledge in Indian pharmaceutical firms: creating competencies for innovation. International Journal of Business Innovation and Research, Vol. 1, Nos, 1 and 2. Gehl Sampath, P. (2006) India's Product Patent Protection Regime: Less or More of “Pills for the Poor”? Journal of World Intellectual Property, 9 (6). pp. 694-726. ISSN 1422-2213 Harmon, S. (2006) . Health Care Analysis 14(4) pp. 215-236. Harmon, S. (2006) The Rules of Re-Engagement: The Use of Patent Proceedings To Influence the Regulation of Science ('What The Salmon Does When Comes Back Downstream'). Intellectual Property Quarterly 4, pp. 378-403. Harmon, S. (2006) From Engagement to Re-Engagement: The Expression of Moral Values in Patenting Proceedings, Present and Future. European Law Review 31(5) pp. 642-666. Gehl Sampath, P. (2005) Regulating Bioprospecting: Institutions for Drug Research, Access and Benefit-Sharing. United Nations University Press, Tokyo, Japan. ISBN 92-808-1112-6, 978-92-808-1112-4 Biotechnology Innovation and Patenting in the Developing World: China - "A Giant Among Nations?" (2007) 12 Journal of Intellectual Property Rights pp.72-85. External Links: http://www.dfid.gov.uk/ http://www.nepad.org/ http://www.wipo.int/portal/index.html.en Further information:
Joanna Chataway, Padmashree Gehl Sampath, Dinar Kale, Joyce Tait, David Wield
The pharmaceutical sector is heavily regulated and this influences industry structure and patterns of innovation. Product safety and efficacy regulation and patent regulation are particularly important in this respect.
Innogen has carried out a wide range of work in relation to this theme and is concerned with both analyzing and understanding the impact of regulations, the way in which regulation interacts with other influences and the potential for revitalising innovation and shaping particular trajectories through regulatory evolution.
Current reseach projects include:
Kale, D. and Wield, D. (2008) . Industry and Innovation, 15 (1). pp. 93-114. ISSN 1366-2716
Archambault, E., Simonetti, R., Côté, G. and Kale, D. (2007) The dynamics of pharmaceutical patenting in India: Evidence from USPTO data. Technology Analysis and Strategic Management, 19 (5). pp. 625-642. ISSN 0953-7325
Chataway, J., Kale, D. and Wield, D. (2007) The Indian pharmaceutical industry before and after TRIPS. Technology Analysis and Strategic Management, 19 (5). pp. 559-563. ISSN 0953-7325
Chataway, J., Tait, J. and Wield, D. (2007) Frameworks for pharmaceutical innovation in developing countries: the case of Indian pharma. Technology Analysis and Strategic Management, 19 (5). pp. 697-708. ISSN 0953-7325
Gehl Sampath, P. (2007) Breaking the fence: can patents deter biomedical innovation in 'Technology Followers'?. Journal of Technology Assessment and Strategic Management, 19 (5). pp. 1-20. ISSN 1465-3990
Kale, D. and Little, S. (2007) From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry. Technology Analysis and Strategic Management, 19 (5). pp. 589-609. ISSN 1465-3990
Chataway, J., Tait, J. and Wield, D. (2006) The governance of agro- and pharmaceutical biotechnology innovation: public policy and industrial strategy. Technology Analysis and Strategic Management, 18 (2). pp. 169-185. ISSN 1465-3990
Tait, J., Chataway, J., Lyall, C. and Wield, D. (2006) Governance, policy and industry strategies: pharmaceuticals and agro-biotechnology. In: Knowledge accumulation and industry evolution: the case of Pharma-Biotech. Cambridge University Press, Cambridge, UK, pp. 378-401. ISBN 0-521-85822-4, 978-0-521-85822-9
Chaturvedi, K. and Chataway, J. (2006) Strategic Integration of knowledge in Indian pharmaceutical firms: creating competencies for innovation. International Journal of Business Innovation and Research, Vol. 1, Nos, 1 and 2.
Gehl Sampath, P. (2006) India's Product Patent Protection Regime: Less or More of “Pills for the Poor”? Journal of World Intellectual Property, 9 (6). pp. 694-726. ISSN 1422-2213
Harmon, S. (2006) . Health Care Analysis 14(4) pp. 215-236.
Harmon, S. (2006) The Rules of Re-Engagement: The Use of Patent Proceedings To Influence the Regulation of Science ('What The Salmon Does When Comes Back Downstream'). Intellectual Property Quarterly 4, pp. 378-403.
Harmon, S. (2006) From Engagement to Re-Engagement: The Expression of Moral Values in Patenting Proceedings, Present and Future. European Law Review 31(5) pp. 642-666.
Gehl Sampath, P. (2005) Regulating Bioprospecting: Institutions for Drug Research, Access and Benefit-Sharing. United Nations University Press, Tokyo, Japan. ISBN 92-808-1112-6, 978-92-808-1112-4 Biotechnology Innovation and Patenting in the Developing World: China - "A Giant Among Nations?" (2007) 12 Journal of Intellectual Property Rights pp.72-85.
http://www.dfid.gov.uk/ http://www.nepad.org/ http://www.wipo.int/portal/index.html.en
